NICE backing for Takeda’s Adcetris for rare lymphoma
Standard of care in untreated systemic anaplastic large cell lymphoma (sALCL) has not changed in several decades
Read More
Tag: ECHELON-2
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
